Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

3Q Pharma Results Preview: Novartis, Merck, Lilly, Bayer, GSK, Bristol, Amgen, Sanofi

Oct 21 2016

• By Scrip Team

Computer key — • Source: Shutterstock

Related Content

Bold Brandicourt Plots Mega Sanofi And Boehringer Animal, Consumer Asset Swap

Dec 15 2015

FDA OK's Lilly's Taltz; Rival To Novartis' Cosentyx

Mar 23 2016

'Total Disaster' In First-Line Lung Cancer For BMS's Opdivo

Oct 10 2016

Novartis CDK4/6 Profile Boosted But Challenge To Pfizer Rival Uncertain

Oct 10 2016

Merck's Keytruda Chemo-Combo Data Has Big Implications For Future Of Immuno-Oncology

Oct 10 2016

From Solanezumab To Solithromycin: What To Watch For In Q4

Oct 11 2016

ESMO Preview: Opdivo Under Pressure

Oct 05 2016

Amgen Earnings Beat Expectations; Company Pushing Payers On Repatha

Apr 29 2016

Genentech’s Tecentriq Stakes New Claim With FDA Lung Cancer Approval

Oct 19 2016

Lilly Executes Growth Strategy As New Products Drive Sales Gains

Apr 27 2016

Fourth EU Opdivo Approval Pending, But BMS Won't Gain Much

Oct 14 2016

Pfizer Sets Inflectra Launch Date; J&J Plans To Fight Back

Oct 18 2016

J&J Maintains Strategy For Biosimilar Remicade As Inflectra Nears

Oct 18 2016

Lilly's Lartruvo Scores Broad FDA Approval In Orphan Sarcomas

Oct 19 2016

Novartis' Siponimod Emerges With Solid Safety, Skirts Gilenya's Heart Effects

Sep 19 2016

GSK’s New CEO Designate Walmsley Fortifies Volume Growth Strategy

Sep 20 2016

Sanofi, Google’s Verily Enter Diabetes JV To Produce Joined Up Solutions

Sep 12 2016

Indication-Based Pricing Could Be Windfall For Interleukin Inhibitors

Sep 13 2016

GSK Shingles Vaccine Adds Evidence It Can Outperform Merck’s Zostavax

Sep 15 2016

Lilly Awaits New Rewards For SGLT-2 Diabetes Drug Jardiance

Jul 27 2016

Strong 2Q And Fresh UK Investment Signal Few Brexit Blues at GSK

Jul 27 2016

Lilly BioMedicines Head Ricks Tasked With Overseeing Growth Phase As Next CEO

Jul 28 2016

Amgen Plugs Away On Repatha, With Hope For New Monthly Product

Jul 28 2016

Amgen Files Osteoporosis Drug In US Ahead Of Rival Merck

Jul 22 2016

Speed Is Everything In CGRP Race As Amgen/Novartis Reveal Phase III Data

Sep 30 2016

UnitedHealthcare Prefers Basaglar Biosimilar At Lantus' Expense

Sep 22 2016

Amgen's Amjevita Approved As First Biosimilar To AbbVie's Humira

Sep 24 2016

Amgen's Kyprolis Miss In First-Line Myeloma Surprising, But Clinically Irrelevant

Sep 27 2016

Sanofi Could Pursue Other Oncology M&A Targets After Medivation Loss

Aug 24 2016

Amgen Gets Parsabiv CRL, Gives No Clues As To Why

Aug 25 2016

Rise Of The Biosimilar Formulary: CVS Excludes Lantus, Neupogen For 2017

Aug 03 2016

CVS Expands Formulary Exclusions In 2017, Express Scripts’ Tally Unchanged

Aug 03 2016

Related Companies

GSK plc

Johnson & Johnson

Novartis AG

Alcon Inc.

Merck & Co., Inc.

Bristol Myers Squibb Company

Roche Holding AG

Eli Lilly and Company

Bayer AG

Lupin Limited

Viatris Inc.

Galderma S.A.

Allergan plc

Almirall SA

LEO Pharma A/S

Cadila Pharmaceuticals Ltd.

Torrent Pharmaceuticals Ltd.

Pfizer Inc.

Additional Topics

Sales & Earnings Companies Commercial Business Strategies BioPharmaceutical

More from Earnings

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.